Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

BACKGROUND: This study investigated the survival benefits of sorafenib vs. radiotherapy (RT) in patients with unresectable hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in the main trunk or the first branch. METHODS: Ninety-seven patients were retrospectively reviewed. Forty...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakazawa, Takahide, Hidaka, Hisashi, Shibuya, Akitaka, Okuwaki, Yusuke, Tanaka, Yoshiaki, Takada, Juichi, Minamino, Tsutomu, Watanabe, Masaaki, Kokubu, Shigehiro, Koizumi, Wasaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014748/
https://www.ncbi.nlm.nih.gov/pubmed/24886354
http://dx.doi.org/10.1186/1471-230X-14-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014748/
https://www.ncbi.nlm.nih.gov/pubmed/24886354
http://dx.doi.org/10.1186/1471-230X-14-84

Ejemplares similares